News

The results of the trial confirmed that as predicted, KP201 is cleaved in man, releasing the active pharmaceutical compound hydrocodone into the bloodstream at amounts equivalent to the

MuGard is a novel, ready-to-use mucoadhesive oral wound rinse and coating for the management of oral mucositis, a debilitating side effect of many anticancer treatments. eMAX Health Systems

Originally, the licensing agreement was signed between BMS and AMRI in 2005. Under the agreement, AMRI has licensed BMS its technology around central nervous system (CNS) triple reuptake

The company expects to recruit around 900 patients suffering from moderate-to-severe blepharitis in a four-arm trial designed to evaluate both product candidates simultaneously. The efficacy and safety of

The Phase 1 study will evaluate the safety, tolerability, pharmacokinetic profile and antiviral activity of ACH-2684. The trial aims to enroll around 78 healthy subjects and 40 HCV

With this acquisition, Abcam will enhance its manufacturing and product development capability, particularly in the exciting area of assay development. Following the acquisition, the employees of MitoSciences will

Radius products include BA058 Injection and BA058 Microneedle Patch. The BA058 Microneedle Patch uses 3M’s patented Microstructured Transdermal System microneedle technology to administer BA058 through the skin, as

Cetirizine Oral Solution is an antihistamine, indicated for the relief sneezing, runny nose, itchy, watery eyes and itchy throat or nose due to indoor and outdoor allergies and

The company has recruited around 90 patients at four sites which include Mount Sinai School of Medicine in New York City, Wake Research Associates in Raleigh, NC, Dermatology